StonvexLoading…
StonvexCore line items from AGI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.81B | $1.35B | $1.02B | $821.20M |
Operating Income | $1.10B | $561.90M | $318.10M | $111.50M |
Net Income | $885.80M | $284.30M | $210.00M | $37.10M |
EPS (Diluted) | $2.10 | $0.69 | $0.53 | $0.09 |
Total Assets | $6.38B | $5.34B | $4.00B | $3.67B |
Total Liabilities | $1.94B | $1.75B | $1.08B | $953.10M |
Cash & Equivalents | $623.10M | $327.20M | $224.80M | $129.80M |
Free Cash Flow OCF − CapEx | $288.20M | $243.50M | $123.80M | $-15.20M |
Shares Outstanding | Not available | Not available | Not available | Not available |